“…[21][22][23] A number of publications on chronic inflammatory and auto-immune disorders have reported that neutrophils and mast cells are the predominant source of IL-17. [23][24][25] To elucidate the localization and phenotype of IL-17 expressing cells, we performed an extensive analysis of the cell types that express IL-17 in cervical cancer. Subsequently, we investigated the distribution of the main IL-17 expressing cell populations in head and neck, ovarian, endometrial, prostate, breast, lung, and colon cancer.…”